Clearlake Capital-backed Symplr has made seven acquisitions since CEO BJ Schaknowski joined the healthcare IT company in November 2020, and says Symplr will continue to grow through M&A. “Everything is for sale,” Schaknowski tells Mergers & Acquisitions.

In 2021, Charlesbank Capital Partners took a minority stake in Symplr, and earlier this year, the target received a new investment from Clearlake which will give Symplr access to $1.6 billion in capital to help it grow organically and through acquisitions.

“We maintain a really healthy database of potential acquisitions,” Schaknowski says. “We got a couple of hundred that we watch really closely. The good news is that everything is for sale so we can be a little bit choosy about what we plug into the platform.” He adds that is quicker to grow Symplr through acquisitions, and the company will stay U.S. focused.

Symplr recently purchased GreenLight Medical, a provider of healthcare management software, and also completed its deal for Midas Health Analytics Solutions.

“Everyone is shopping themselves to some degree which makes it great for us,” he says. “We’ll continue to look for the right tuck-ins.”

Now on to the next one.

Demitri Diakantonis